Evaluation of therapeutic response using
✍
L. Camera; S. Vecchio; A. Petrillo; G. Esposito; G. Frasci; R. V. Iaffaioli; A.
📂
Article
📅
1991
🏛
Springer
🌐
English
⚖ 755 KB
We used radiolabelled monoclonal antibodies (MoAbs) to prove disease persistence after treatment for ovarian carcinoma. Twelve patients with histologically confirmed ovarian carcinoma were studied. They received 5 mCi (1 mg) of iodine-131-B72.3 by intravenous injection before and after a complete co